Matrisome gene-based subclassification of patients with liver fibrosis identifies clinical and molecular heterogeneities

The microfibrillar-associated protein 4 + -activated HSC-derived LFMG signature classifies patients with liver fibrosis with distinct clinical and biological characteristics. Our findings unveil hidden information from liver biopsies undetectable using traditional histologic assessments.